Fas receptor (CD95) & Fas ligand (CD178) expression in patients with tobacco-related intraoral squamous cell carcinoma

BACKGROUND & OBJECTIVES: Fas receptor and Fas Ligand (FasL) system has been implicated in the resistance to apoptosis, insensitivity to chemotherapy and in providing immune privileged status to most of the tumours. However, no reports are available on Fas and FasL expression in patients with tob...

Descripción completa

Detalles Bibliográficos
Autores principales: Das, Satya N., Khare, Pratima, Singh, Manoj K., Sharma, Suresh C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3171918/
https://www.ncbi.nlm.nih.gov/pubmed/21808135

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3171918/
https://www.ncbi.nlm.nih.gov/pubmed/21808135

Ejemplares similares